Yuji Nakatsuji Selected Research

Yuji Nakatsuji Research Topics

Disease

15	Multiple Sclerosis 05/2021 - 10/2004
9	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2018 - 10/2004
8	Neuromyelitis Optica (Devic's Disease) 01/2023 - 03/2009
6	Inflammation (Inflammations) 02/2015 - 03/2010
5	Neuroinflammatory Diseases 06/2021 - 02/2010
4	Parkinson Disease (Parkinson's Disease) 04/2024 - 09/2005
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 06/2021 - 10/2004
4	Polyneuropathies (Polyneuropathy) 05/2021 - 01/2017
3	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 12/2011
3	Demyelinating Diseases (Demyelinating Disease) 01/2017 - 11/2011
3	Necrosis 01/2012 - 10/2004
2	Myasthenia Gravis 01/2024 - 05/2021
2	Encephalitis (Encephalitis, Rasmussen) 05/2021 - 10/2018
2	Guillain-Barre Syndrome 05/2021 - 01/2018
2	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 01/2021 - 01/2017
2	Relapsing-Remitting Multiple Sclerosis 03/2020 - 01/2018
1	Muscle Weakness 01/2024
1	Dyspnea (Shortness of Breath) 01/2024
1	Hepatocellular Carcinoma (Hepatoma) 01/2024
1	Liver Neoplasms (Liver Cancer) 01/2024
1	Myocarditis (Carditis) 01/2024
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2024
1	Ataxia (Dyssynergia) 08/2023
1	Chorea (Rheumatic Chorea) 08/2023
1	Lung Neoplasms (Lung Cancer) 08/2023
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 08/2023
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023
1	Optic Neuritis (Retrobulbar Neuritis) 12/2021
1	Movement Disorders (Movement Disorder) 10/2021
1	Nervous System Diseases (Neurological Disorders) 05/2021
1	Autoimmune Diseases of the Nervous System 05/2021
1	MELAS Syndrome (Syndrome, MELAS) 01/2020
1	Infections 10/2019
1	Bacterial Meningitis 10/2019
1	Disease Progression 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Respiratory Insufficiency (Respiratory Failure) 05/2018
1	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 05/2018
1	Neuroendocrine Carcinoma 02/2018
1	Polyradiculoneuropathy (Polyradiculoneuritis) 01/2018
1	Arthritis (Polyarthritis) 02/2015
1	Rheumatoid Arthritis 02/2015

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2012
3	Xanthine OxidaseIBA 04/2024 - 01/2013
3	anti-aquaporin 4 autoantibodyIBA 05/2021 - 03/2010
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2020 - 01/2011
3	Immunoglobulin G (IgG)IBA 10/2018 - 03/2009
3	AutoantibodiesIBA 10/2018 - 03/2009
3	Semaphorins (Semaphorin)IBA 09/2015 - 06/2006
3	CytokinesIBA 02/2015 - 10/2004
2	Proteins (Proteins, Gene)FDA Link 08/2023 - 01/2017
2	Adenosine Triphosphate (ATP)IBA 06/2021 - 01/2020
2	Acetates (Acetic Acid Esters)FDA Link 01/2021 - 01/2014
2	Mitochondrial DNA (mtDNA)IBA 01/2020 - 04/2018
2	Methylprednisolone FDA LinkGeneric 01/2016 - 01/2015
2	Interleukin-6 (Interleukin 6)IBA 02/2015 - 03/2013
2	ChemokinesIBA 02/2015 - 03/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2013 - 08/2008
2	Complement System Proteins (Complement)IBA 01/2012 - 03/2009
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2005 - 10/2004
1	AntioxidantsIBA 04/2024
1	atezolizumabIBA 01/2024
1	Immune Checkpoint InhibitorsIBA 01/2024
1	durvalumabIBA 08/2023
1	Semaphorin-3AIBA 08/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	HLA-DRB1*04 antigenIBA 12/2021
1	HLA-DRB1 Chains (HLA DRB1)IBA 12/2021
1	3-Iodobenzylguanidine (Iobenguane)IBA 10/2021
1	neuromelaninIBA 10/2021
1	Carboxy-LyasesIBA 10/2021
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 10/2021
1	Dopa DecarboxylaseIBA 10/2021
1	Monoamine Oxidase (MAO)IBA 10/2021
1	Adenosine (Adenocard)FDA LinkGeneric 06/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021
1	Interleukin-17 (Interleukin 17)IBA 03/2020
1	LuciferasesIBA 01/2020
1	Methicillin (Metin)FDA Link 10/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2019
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2019
1	Vasodilator Agents (Vasodilators)IBA 01/2019
1	Glutamic Acid (Glutamate)FDA Link 01/2019
1	CDw17 antigen (lactosylceramide)IBA 05/2018
1	Calcium Channels (Calcium Channel)IBA 02/2018
1	AntibodiesIBA 02/2018
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2018
1	NivolumabIBA 01/2018
1	Febuxostat FDA Link 01/2017
1	EpiregulinIBA 02/2015
1	AmphiregulinIBA 02/2015
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 02/2015
1	TenascinIBA 02/2015
1	BetacellulinIBA 02/2015

Therapy/Procedure

10	Therapeutics 10/2019 - 10/2004
2	Transcranial Direct Current Stimulation 10/2021 - 01/2018
2	Plasma Exchange 05/2021 - 01/2017
1	Transcranial Magnetic Stimulation 10/2021
1	Blood Component Removal (Apheresis) 05/2021
1	Artificial Respiration (Mechanical Ventilation) 05/2018